➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
AstraZeneca
Mallinckrodt
Baxter
Moodys

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Iopamidol - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for iopamidol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1
QED Therapeutics, Inc.Phase 1
Breast Cancer Research FoundationPhase 1

See all iopamidol clinical trials

Pharmacology for iopamidol
Medical Subject Heading (MeSH) Categories for iopamidol

US Patents and Regulatory Information for iopamidol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare IOPAMIDOL iopamidol INJECTABLE;INJECTION 074629-003 Nov 6, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira IOPAMIDOL-370 IN PLASTIC CONTAINER iopamidol INJECTABLE;INJECTION 074636-004 Dec 30, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira IOPAMIDOL-300 iopamidol INJECTABLE;INJECTION 075005-002 Feb 24, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for iopamidol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco ISOVUE-200 iopamidol INJECTABLE;INJECTION 020327-001 Oct 12, 1994   Start Trial   Start Trial
Bracco ISOVUE-300 iopamidol INJECTABLE;INJECTION 018735-002 Dec 31, 1985   Start Trial   Start Trial
Bracco ISOVUE-M 300 iopamidol INJECTABLE;INJECTION 018735-004 Dec 31, 1985   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Moodys
Boehringer Ingelheim
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.